-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DxxLyPaFLe37AATgDXQEQzkR9Z/h6OTObO9CEHewnhv1LlQuyZAXAXZfbE9/e/h1 gnzV0PV3Jvko+dRBm73NRA== 0000912057-01-006070.txt : 20010223 0000912057-01-006070.hdr.sgml : 20010223 ACCESSION NUMBER: 0000912057-01-006070 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: KOSAN BIOSCIENCES INC CENTRAL INDEX KEY: 0001110206 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943217016 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-60269 FILM NUMBER: 1548325 BUSINESS ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5107328400 MAIL ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KHOSLA CHAITAN PHD CENTRAL INDEX KEY: 0001135139 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5107328400 MAIL ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 SC 13G 1 a2039235zsc13g.txt FORM 13G ----------------------------------- OMB APPROVAL ----------------------------------- ----------------------------------- OMB Number: 3235-0145 ----------------------------------- ----------------------------------- Expires: October 31, 2002 ----------------------------------- ----------------------------------- Estimated average burden hours per response...........14.9 ----------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. )* Kosan Biosciences Incorporated - -------------------------------------------------------------------------------- (Name of Issuer) - -------------------------------------------------------------------------------- Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) - -------------------------------------------------------------------------------- 50064W 10 7 - -------------------------------------------------------------------------------- (CUSIP Number) - -------------------------------------------------------------------------------- December 31, 2000 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) - -------------------------------------------------------------------------------- Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) / / Rule 13d-1(c) /x/ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 50064W 10 7 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Chaitan Khosla, Ph.D. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / (b) / / - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- Number of Shares Beneficially Owned by Each Reporting 5. Sole Voting Power 195,000 Person With ---------------------------------------------------------- 6. Shared Voting Power 1,590,000 ---------------------------------------------------------- 7. Sole Dispositive Power 195,000 ---------------------------------------------------------- 8. Shared Dispositive Power 1,590,000 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,785,000 - -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (11) 7.1% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) IN - -------------------------------------------------------------------------------- ITEM 1. (a) Name of Issuer Kosan Biosciences Incorporated (b) Address of Issuer's Principal Executive Offices 3832 Bay Center Place Hayward, CA 94545 ITEM 2. (a) Name of Person Filing Chaitan Khosla, Ph.D. (b) Address of Principal Business Office or, if none, Residence c/o Kosan Biosciences Incorporated 3832 Bay Center Place Hayward, CA 94545 (c) Citizenship United States (d) Title of Class of Securities Common Stock (e) CUSIP Number 50064W107 ITEM 3. Not applicable ITEM 4. OWNERSHIP Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owed: 1,785,000 ------------- (b) Percent of class: 7.1% ---------- (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 195,000 ------- (ii) Shared power to vote or to direct the vote 1,590,000 ---------- (iii) Sole power to dispose or to direct the disposition of 195,000 ------- (iv) Shared power to dispose or to direct the disposition of 1,590,000 --------- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable ITEM 10. CERTIFICATION Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 2001 ------------------------------------- Date /s/ Chaitan Khosla, Ph.D. ------------------------------------- Signature Chaitan Khosla, Ph.D./Director ------------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----